Benjamin Povinelli

Benjamin Povinelli has a diverse work experience in the field of scientific research and development. Benjamin started their career at Roswell Park Comprehensive Cancer Center in 2008, where they worked as a Pre-doctoral Scientist until 2014. Following that, they joined the University of Oxford as a Postdoctoral Scientist, where they worked from 2014 to 2019. After that, they joined the FDA as a Senior Staff Fellow from 2019 to 2021. Currently, they are working at CytomX Therapeutics, where they started in 2021 as a Senior Scientist and later promoted to Senior Scientist 2.

Benjamin Povinelli completed their Bachelor of Science (BS) degree in Biochemistry from SUNY Geneseo in the years 2004 to 2008. Benjamin then pursued further education and obtained their Doctor of Philosophy (PhD) in Cell/Cellular and Molecular Biology from the University at Buffalo between 2008 and 2014. It is not known at this time whether Benjamin Povinelli pursued any education at the University of Oxford, as the start and end years, as well as the degree and field of study, are unavailable.